Consistent with the role of Akt activation in facilitating cell proliferation and survival [20], 7Bi treatment reduced the growth of multiple NSCLC cells including A549 (Figure 3M,N and Figure S2E), H520 (Figure 3O and Figure S2F) and H1299 (Figure 3P and Figure S2G), as well as HEK293 cells (Figure 3Q). Here, AKT1 is linked to non-small cell lung carcinoma.